CHINA PHARMA HOLDINGS, INC. Long-Term Debt, Maturity, Year Three
CHINA PHARMA HOLDINGS, INC. (CPHI) had Long-Term Debt, Maturity, Year Three of $2.12 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2019-11-14
- 2019-09-30: Long-Term Debt, Maturity, Year Three $2.12M.
- 2019-06-30: Long-Term Debt, Maturity, Year Three $2.04M.
- 2019-03-31: Long-Term Debt, Maturity, Year Three $2.09M.
- 2018-12-31: Long-Term Debt, Maturity, Year Three $2.18M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2019-09-30 | $2.12M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.04M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.09M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $2.18M 10-K · filed 2019-03-28 |
| 2018-09-30 | $2.18M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.27M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.39M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $2.31M 10-K · filed 2018-04-02 |
| 2017-09-30 | $2.29M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $2.21M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |